Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

• DRUG: Part A: RPL554
• DRUG: Part B: RPL554
• DRUG: Placebos

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Collaborators

• [object Object]